Curcumin and cancer: barriers to obtaining a health claim.

Curcumin is a highly pleiotropic molecule found in the rhizomes of Curcuma longa (turmeric). It is responsible for the yellow color of turmeric and has been shown to inhibit the proliferation of cancer cells and to be of use in preventing or treating a number of diseases. Curcumin has been shown to modulate multiple cell-signaling pathways simultaneously, thereby mitigating or preventing many different types of cancers, including multiple myeloma and colorectal, pancreatic, breast, prostate, lung, head, and neck cancers, in both animal models and humans. Current therapeutic approaches using a single cancer drug for a single target can be expensive, have serious side effects, or both. Consequently, new approaches to the treatment and prevention of cancer, including the integration of curcumin as a viable treatment strategy where dysregulation of many pathways is involved, are warranted. A methodical review of the evidence was performed to evaluate the effects of curcumin in support of a health claim, as established through the regulatory framework of Health Canada, for a relationship between the consumption of curcumin and the prevention and treatment of cancer.

[1]  S. Joyal,et al.  A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95®CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin , 2008, Indian journal of pharmaceutical sciences.

[2]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[3]  R. Planalp,et al.  Curcumin: From ancient medicine to current clinical trials , 2008, Cellular and Molecular Life Sciences.

[4]  B. Stewart,et al.  World cancer report 2014. , 2014 .

[5]  G. Dontu,et al.  Targeting breast stem cells with the cancer preventive compounds curcumin and piperine , 2010, Breast Cancer Research and Treatment.

[6]  M. Pirmohamed,et al.  Phase I Clinical Trial of Oral Curcumin , 2004, Clinical Cancer Research.

[7]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[8]  A. Shehzad,et al.  Molecular mechanisms of curcumin action: Signal transduction , 2013, BioFactors.

[9]  Havva Şahin Kavaklı,et al.  Sıçanlarda spinal kord yaralanmsında curcuminin antioksidan etkileri , 2011 .

[10]  Makoto Takahashi,et al.  Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. , 2009, Journal of agricultural and food chemistry.

[11]  B. Aggarwal,et al.  Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. , 2007, Carcinogenesis.

[12]  F. Ruscetti,et al.  Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. , 1997, Cancer research.

[13]  E. Larsson,et al.  Antioxidants Accelerate Lung Cancer Progression in Mice , 2014, Science Translational Medicine.

[14]  S. Wexner,et al.  Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[16]  B. Aggarwal,et al.  Multitargeting by turmeric, the golden spice: From kitchen to clinic. , 2013, Molecular nutrition & food research.

[17]  R. Ramakrishna,et al.  Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double‐blind placebo‐controlled cross‐over 4g study and an open‐label 8g extension study , 2012, American journal of hematology.

[18]  D. Heber,et al.  Role of tomatoes, tomato products and lycopene in cancer prevention. , 2001, Advances in experimental medicine and biology.

[19]  R. Benya,et al.  Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia , 2011, Cancer Prevention Research.

[20]  B. Stefańska Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus – insights into its mechanisms of action , 2012, British journal of pharmacology.

[21]  Z. Chen,et al.  New Perspectives of Curcumin in Cancer Prevention , 2013, Cancer Prevention Research.

[22]  Daniel Normolle,et al.  Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.

[23]  Hailong Yu,et al.  Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. , 2012, Journal of agricultural and food chemistry.

[24]  B. Aggarwal,et al.  Curcumin and cancer: an "old-age" disease with an "age-old" solution. , 2008, Cancer letters.

[25]  B. Patel,et al.  Colorectal Cancer: Chemopreventive Role of Curcumin and Resveratrol , 2010, Nutrition and cancer.

[26]  T. Tsai,et al.  Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  Zhenyu Ji,et al.  Targeting DNA Damage and Repair by Curcumin , 2010, Breast cancer : basic and clinical research.

[28]  B. Aggarwal,et al.  Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively? , 2009, The AAPS Journal.

[29]  B. Patel,et al.  Synergistic Role of Curcumin With Current Therapeutics in Colorectal Cancer: Minireview , 2009, Nutrition and cancer.

[30]  M. Kanai Therapeutic applications of curcumin for patients with pancreatic cancer. , 2014, World journal of gastroenterology.

[31]  C. Aebi,et al.  Antibacterial and Antiinflammatory Kinetics of Curcumin as a Potential Antimucositis Agent in Cancer Patients , 2012, Nutrition and cancer.

[32]  A. Wolk,et al.  Vitamin C and survival among women with breast cancer: a meta-analysis. , 2014, European journal of cancer.

[33]  Liandong Hu,et al.  Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle. , 2012, Journal of agricultural and food chemistry.

[34]  A. Ingle,et al.  Inhibitory effects of curcumin-free aqueous turmeric extract on benzo[a]pyrene-induced forestomach papillomas in mice. , 1997, Cancer letters.

[35]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[36]  Zhenyu Ji Article Commentary: Targeting DNA Damage and Repair by Curcumin , 2010 .

[37]  J. Mellon,et al.  Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). , 2003, International journal of oncology.

[38]  A. Ingle,et al.  Chemopreventive efficacy of curcumin-free aqueous turmeric extract in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis. , 1998, Cancer letters.

[39]  A. Munshi,et al.  Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats. , 2010, Methods and findings in experimental and clinical pharmacology.

[40]  S. Mukherjee,et al.  Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[41]  J. Pedraza-Chaverri,et al.  Renoprotective effect of the antioxidant curcumin: Recent findings , 2013, Redox biology.

[42]  Jeffrey R. Wang,et al.  The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer , 2013, Oncology reports.

[43]  Zhiwei Wang,et al.  Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. , 2010, Current pharmaceutical design.

[44]  M. Majeed,et al.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.

[45]  Jun Li,et al.  Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. , 2013, Current pharmaceutical design.

[46]  K. Prasad,et al.  High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. , 1999, Journal of the American College of Nutrition.

[47]  V. Ghalaut,et al.  Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia , 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[48]  Takuji Tanaka,et al.  Chemopreventive Effect of Curcumin on N‐Nitrosomethylbenzylamine‐induced Esophageal Carcinogenesis in Rats , 2000, Japanese journal of cancer research : Gann.

[49]  P. Jones,et al.  Generic and product-specific health claim processes for functional foods across global jurisdictions. , 2008, The Journal of nutrition.

[50]  Jaetae Lee,et al.  Curcumin in various cancers , 2013, BioFactors.

[51]  R. D'Agostino,et al.  Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. , 2009, Blood.

[52]  Y. Oshima,et al.  Antihepatotoxic Principles of Curcuma longa Rhizomes1 , 1983, Planta medica.

[53]  N. Vermeulen,et al.  Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. , 2007, Toxicology.

[54]  G. Appendino,et al.  Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. , 2011, Journal of natural products.

[55]  H. Lou,et al.  Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. , 2006, Journal of pharmaceutical and biomedical analysis.

[56]  P. Suryanarayana,et al.  Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. , 2005, Investigative ophthalmology & visual science.

[57]  C. Koca,et al.  Antioxidant effects of curcumin in spinal cord injury in rats. , 2011, Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES.

[58]  Razelle Kurzrock,et al.  Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer , 2008, Clinical Cancer Research.

[59]  S. Horie,et al.  Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate‐specific antigen , 2010, The Prostate.

[60]  Namitha,et al.  A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. , 2005, The Indian journal of medical research.

[61]  Jacob M. Wilson,et al.  Comparative absorption of curcumin formulations , 2014, Nutrition Journal.

[62]  M. L’Abbé,et al.  Health claims on foods in Canada. , 2008, The Journal of nutrition.

[63]  T. Shanafelt,et al.  Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG , 2009, Clinical Cancer Research.

[64]  R. Basha,et al.  The impact of curcumin on breast cancer. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[65]  B. Aggarwal,et al.  Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. , 2012, Molecular nutrition & food research.

[66]  Jianguo Lin,et al.  Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2 , 2011, Molecular and Cellular Endocrinology.

[67]  Y. Makino,et al.  Novel curcumin oral delivery systems. , 2013, Anticancer research.

[68]  S. Nakornchai,et al.  Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. , 2007, Biological & pharmaceutical bulletin.

[69]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[70]  M. Mouret-Reynier,et al.  Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer , 2010, Cancer biology & therapy.

[71]  G. Bar-Sela,et al.  Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer , 2010, Nutrition and cancer.

[72]  M. Fujita,et al.  Innovative preparation of curcumin for improved oral bioavailability. , 2011, Biological & pharmaceutical bulletin.

[73]  Chi-Hsien Liu,et al.  Antimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidis. , 2012, Chemical & pharmaceutical bulletin.

[74]  S. Mukherjee,et al.  Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity , 2007, Molecular and Cellular Biochemistry.

[75]  D. Tuveson,et al.  The promise and perils of antioxidants for cancer patients. , 2014, The New England journal of medicine.

[76]  J. Pedraza-Chaverri,et al.  Mitochondria as a Target in the Therapeutic Properties of Curcumin , 2014, Archiv der Pharmazie.

[77]  Serge Eifes,et al.  Chemopreventive potential of curcumin in prostate cancer , 2010, Genes & Nutrition.

[78]  B. Aggarwal,et al.  Curcumin, a component of turmeric: From farm to pharmacy , 2013, BioFactors.

[79]  T. Salo,et al.  Nutraceuticals as new treatment approaches for oral cancer--I: Curcumin. , 2013, Oral oncology.

[80]  S. Sagar Antioxidants during anticancer therapy , 2004, Focus on Alternative and Complementary Therapies.

[81]  Ricky A. Sharma,et al.  Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[82]  Chuanbing Shi,et al.  Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin , 2011, Cancer investigation.

[83]  K. Prasad,et al.  Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in culture. , 1996, Nutrition and cancer.

[84]  A. Shehzad,et al.  Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review , 2010, Drugs of the Future.

[85]  Mi-Kyung Lee,et al.  Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. , 2008, Molecular nutrition & food research.

[86]  Yan-yan Xing,et al.  Curcumin Protects Microglia and Primary Rat Cortical Neurons against HIV-1 gp120-Mediated Inflammation and Apoptosis , 2013, PloS one.

[87]  M. Vinayak,et al.  Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice. , 2012, Bioscience reports.

[88]  R. Means Ironing out complementary medicine. , 2009, Blood.

[89]  V. Menon,et al.  Protective effect of curcumin on gamma-radiation induced DNA damage and lipid peroxidation in cultured human lymphocytes. , 2006, Mutation research.

[90]  Luciana Facco Dalmolin,et al.  Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. , 2013, Colloids and surfaces. B, Biointerfaces.

[91]  M. Chan,et al.  Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model , 2008, Laboratory Investigation.

[92]  H. Kishida,et al.  Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. , 2005, Journal of agricultural and food chemistry.

[93]  C. Heckler,et al.  Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients , 2013, Radiation research.

[94]  R. Salganik The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population , 2001, Journal of the American College of Nutrition.

[95]  T. Osawa,et al.  Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. , 1996, Biochemical pharmacology.

[96]  H. Ammon,et al.  Pharmacology of Curcuma longa , 1991, Planta medica.

[97]  T. Kajiwara Breast-Conserving therapy: Experience of the breast cancer research group of Tokyo women’s medical college , 1997, Breast cancer.

[98]  G. Nair,et al.  Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.

[99]  Donald J L Jones,et al.  Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[100]  Jun Cao,et al.  Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[101]  A. Nagler,et al.  Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells. , 1999, Radiation research.